Alkermes PLC $43.68

down -0.67


15/9/2014 04:00 PM  |  NASDAQ : ALKS  
Industries : Drugs / Drug Delivery & Accessories
Get Trend Analysis Icon Get ALKS Trend Analysis - it has outperformed the S&P 500 by 10%

Partner Headlines

  1. Alkermes Announces Completion Of Patient Enrollment In Phase 2 Study Of ...

    Benzinga
  2. US Stock Futures Rise Ahead Of Economic Data

    Benzinga
  3. Morgan Stanley Sees EPS Below Consensus, Robust Pipeline For Alkermes plc

    Benzinga
  4. Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest Revenue

    Benzinga
  5. Alkermes' drug passes trial

    IBD
  6. Market Wrap For April 8: Markets Bounce Higher As Earnings Season Begins

    Benzinga
  7. Stocks Rise, Led By Tech Stocks, But Volume Fades

    IBD
  8. Mid-Afternoon Market Update: Markets Recover Slightly as Coal Shows Strength

    Benzinga
  9. Mid-Day Market Update: US Stocks Gain; Gigamon Shares Dip On Lower Forecast

    Benzinga
  10. Alkermes' Schizophrenia Drug Passes Trial; Filing In Q3

    IBD
  11. Benzinga's Volume Movers

    Benzinga
  12. Mid-Morning Market Update: Markets Mixed; A. Schulman Lifts Profit Outlook

    Benzinga
  13. Morning Market Movers

    Benzinga
  14. Alkermes Announces Positive Topline Results From Pivotal Phase 3 Study ...

    Benzinga
  15. Benzinga's Top Initiations

    Benzinga
  16. Nasdaq Back Above Water; Green Plains Jumps

    IBD
  17. LifeLock, YY Among 5 Stocks With Top Fundamentals

    IBD
  18. Stocks Fall In Higher Volume; Yandex, Twitter Drop

    IBD
  19. Stocks Weaken After Fed Minutes; Thor Rallies

    IBD
  20. Stocks End Short Week With Big Losses

    IBD
  21. Alkermes Announces Advances in Late-Stage CNS Pipeline

    Benzinga
  22. Alkermes Receives Notice of Allowance of US Patent for Novel Fumarate Prodrug ...

    Benzinga
  23. Ireland Home To Several Fast Growing Health Care Names

    IBD
  24. Alkermes Presents Data on Aripiprazole Lauroxil and ALKS 5461 at 52nd Annual ...

    Benzinga
  25. UPDATE: Citigroup Raises PT on Alkermes on Multiple Value Opportunities

    Benzinga
  26. Alkermes, FDA Agree on Deal for Elements of ALKS 5461 Development Program

    Benzinga
  27. Top 4 Stocks In The Drug Delivery Industry With The Highest Cash

    Benzinga
  28. Acceleron Pharma IPO Pops; Fate Therapeutics On Deck

    IBD
  29. Google, LKQ, Tesla: Stocks A Marsico Manager Likes

    IBD
  30. Stocks End Mixed In Light Trade; Green Mountain Spurts Ahead

    IBD
  31. Stocks Down Modestly; Alkermes Ramps Up

    IBD
  32. Alkermes

    IBD
  33. Stocks Up, Google At High; Dow Takes Out 14,000

    IBD
  34. Regeneron, Other Biomed Stocks Rebound On New Drugs

    IBD
  35. Alkermes

    IBD
  36. Stocks Slip As Fed Stands Pat; SodaStream Trims Gain

    IBD
  37. Alkermes Trades Tightly, Holds In Buying Range

    IBD
  38. UPDATE: Credit Suisse Initiates Alkermes at Neutral; Looking For Better ...

    Benzinga
  39. Celgene Leads 6 Medical Stocks With Bolting RS Lines

    IBD
  40. Top 4 Stocks In The Drug Delivery Industry With The Highest EPS Estimates ...

    Benzinga
  41. Stocks Hold Modest Gains; MI Homes Hits Multiyear High

    IBD
  42. Alkermes In Buy Area After Breakout In Strong Volume

    IBD
  43. Stocks Pare Early Losses, End With Modest Declines

    IBD
  44. Alkermes Announces Notice of Allowance of USPTO Application for Aripiprazole ...

    Benzinga
  45. Alkermes Announces Positive Results from Phase 1 Study of ALKS 3831

    Benzinga
  46. Biotech Alkermes Sketches Imperfect Cup With Handle

    IBD
  47. Alkermes' Acquisition Proves To Be Game-Changer

    IBD
  48. Alkermes' Corporate Presentation to be Webcast at Two Upcoming Conferences

    Benzinga
  49. Dow Leads Market Higher As Volume Swells

    IBD
  50. Stocks Add To Gains; DaVita HealthCare Jumps

    IBD
Trading Center